Psychopharmacology and Psychiatry Updates

213 Episodo

1. Balancing Benefits and Risks: Antipsychotics in Hepatic Dysfunction

   Publicado: 25/6/2024
2. Insomnia and Depression: A Tangled Web

   Publicado: 20/6/2024
3. ADHD Treatment During Pregnancy: Insights from Denmark

   Publicado: 15/6/2024
4. The Power of Nonpharmacologic Therapies in Fibromyalgia

   Publicado: 10/6/2024
5. Highlights From APA 2024: Key Insights on Psychopharmacology

   Publicado: 5/6/2024
6. Antidepressants in Pregnancy: Weighing the Evidence

   Publicado: 31/5/2024
7. Unraveling the Pharmacological Puzzle of Fibromyalgia

   Publicado: 26/5/2024
8. Weighing the Evidence: Antipsychotics in Pediatric Anorexia Nervosa

   Publicado: 21/5/2024
9. Beyond the Pain: Diagnosing Fibromyalgia

   Publicado: 17/5/2024
10. Informed Consent and SSRIs: Discussing the Risk of Irreversible Sexual Side Effects

    Publicado: 11/5/2024
11. Mastering Clozapine: Adverse Effect Management

    Publicado: 6/5/2024
12. Preventing Depression and Anxiety Relapse in Youth

    Publicado: 1/5/2024
13. Charting the Clozapine Course: Titration and Monitoring

    Publicado: 26/4/2024
14. Smoking and Psychosis: Insights from the PATH Study

    Publicado: 21/4/2024
15. Clozapine: The Gold Standard for Treatment-Resistant Schizophrenia

    Publicado: 16/4/2024
16. Balancing Benefits and Risks: Lithium in Child and Adolescent Psychiatry

    Publicado: 11/4/2024
17. Orchestrating Nutrition and Medication: Micronutrient Therapy in Practice

    Publicado: 6/4/2024
18. Zuranolone: A New Dawn for Postpartum Depression Treatment

    Publicado: 1/4/2024
19. Micronutrients for Psychiatric Disorders: Optimizing Clinical Use

    Publicado: 27/3/2024
20. Olanzapine in Pregnancy: Examining the Risks

    Publicado: 22/3/2024